Tesla’s technicals, biotech’s bounce and trading stocks at 52-week highs. 11/22/22

Tesla’s stock has been cut in half this year, trading way below the average Wall Street price target. A technician tells us where she thinks the stock goes next. Plus, money has been rotating into biotech stocks. Is the sector recession proof? And the trade on IBM as the stock hits a 52-week high.